Who Paid My Doc
Ukoniq
Drug Hematology
NDC 73150-200-12
General payments
$332,017
Research payments
$16,604,633
Through program year 2025, $332,017 in general payments and $16,604,633 in research payments were reported against Ukoniq (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $387,802 | 9 |
| 2024 | Research | $209,606 | 103 |
| 2023 | Research | $3,180,144 | 1,123 |
| 2022 | General | $105,582 | 451 |
| 2022 | Research | $6,588,866 | 2,296 |
| 2021 | General | $226,435 | 865 |
| 2021 | Research | $6,238,214 | 2,554 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
1,316 general · 6,085 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.